Richard L Martin1, Michael J Grant2, Stephen Kimani3, Shonali Midha4, Jori May5, Rushad Patell6, Emily Collier2, David Furfaro7, Charles Bodine5, Leo Reap8, Nikesh Shah4, Jess DeLaune9, Samuel Brusca10, Coral Olazagasti11, Shreya Goyal11, Samuel Rubinstein12, Nausheen Hakim13, Shuai Qin14, Sabrina L Browning15, Laura Sena16, Jill Gilbert1, Mario Davidson17, Christine M Lovly1, Nagashree Seetharamu18, Deepa Rangachari6, Martina Murphy9, Monica Chatwal4, Rita Paschal19, Elizabeth Henry20, Frances Collichio21, Jennifer R Green1. 1. Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center, Nashville, TN. 2. Section of Hematology-Oncology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT. 3. Department of Medicine, The University of North Carolina, Chapel Hill, NC. 4. H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morsani College of Medicine, Tampa, FL. 5. Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL. 6. Division of Hematology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. 7. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, New York-Presbyterian Hospital, Columbia University Irving Medical Center, New York, NY. 8. Department of Medicine, Ascension Providence Hospital, Detroit, MI. 9. Division of Hematology-Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL. 10. National Institutes of Health Clinical Center, Bethesda, MD. 11. Division of Hematology-Oncology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra University, New Hyde Park, NY. 12. Division of Hematology, Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC. 13. Division of Hematology-Oncology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra University, Long Island, NY. 14. Division of Hematology-Oncology, Department of Internal Medicine, Loyola University Medical Center, Maywood, IL. 15. Division of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT. 16. The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD. 17. Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN. 18. Division of Hematology-Oncology, Donald and Barbara Zucker School of Medicine at Hofstra University, New Hyde Park, NY. 19. Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL. 20. Division of Hematology-Oncology, Department of Internal Medicine, Department of Medical Education, Loyola University Medical Center, Maywood, IL. 21. Division of Hematology Oncology, Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.
Abstract
PURPOSE: COVID-19 challenged medical practice and graduate medical education. Building on previous initiatives, we describe and reflect on the formative process and goals of the Hematology-Oncology Collaborative Videoconferencing Learning Initiative, a trainee-led multi-institutional virtual COVID-19 learning model. METHODS: Clinical fellows and faculty from 13 US training institutions developed consensus needs, goals, and objectives, recruited presenters, and generated a multidisciplinary COVID-19 curriculum. Weekly Zoom conferences consisted of two trainee-led instructional segments and a trainee-moderated faculty Q&A panel. Hematology-oncology training program faculty and trainees were the targeted audience. Leadership evaluations consisted of anonymized baseline and concluding mixed methods surveys. Presenter evaluations consisted of session debriefs and two structured focus groups. Conference evaluations consisted of attendance, demographics, and pre- or postmultiple-choice questions on topic learning objectives. RESULTS: In 6 weeks, the initiative produced five conferences: antivirals, anticoagulation, pulmonology, provider resilience, and resource scarcity ethics. The average attendance was 100 (range 57-185). Among attendees providing both pre- and postconference data, group-level knowledge appeared to increase: antiviral (n = 46) pre-/postcorrect 82.6%/97.8% and incorrect 10.9%/2.2%, anticoagulation (n = 60) pre-/postcorrect 75%/93.3% and incorrect 15%/6.7%, and pulmonary (n = 21) pre-/postcorrect 66.7%/95.2% and incorrect 33.3%/4.8%. Although pulmonary management comfort appeared to increase, comfort managing of antivirals and anticoagulation was unchanged. At the conclusion of the pilot, leadership trainees reported improved self-confidence organizing multi-institutional collaborations, median (interquartile range) 58.5 (50-64) compared with baseline 34 (26-39), but did not report improved confidence in other educational or leadership skills. CONCLUSION: During crisis, trainees built a multi-institutional virtual education platform for the purposes of sharing pandemic experiences and knowledge. Accomplishment of initiative goals was mixed. Lessons learned from the process and goals may improve future disaster educational initiatives.
PURPOSE: COVID-19 challenged medical practice and graduate medical education. Building on previous initiatives, we describe and reflect on the formative process and goals of the Hematology-Oncology Collaborative Videoconferencing Learning Initiative, a trainee-led multi-institutional virtual COVID-19 learning model. METHODS: Clinical fellows and faculty from 13 US training institutions developed consensus needs, goals, and objectives, recruited presenters, and generated a multidisciplinary COVID-19 curriculum. Weekly Zoom conferences consisted of two trainee-led instructional segments and a trainee-moderated faculty Q&A panel. Hematology-oncology training program faculty and trainees were the targeted audience. Leadership evaluations consisted of anonymized baseline and concluding mixed methods surveys. Presenter evaluations consisted of session debriefs and two structured focus groups. Conference evaluations consisted of attendance, demographics, and pre- or postmultiple-choice questions on topic learning objectives. RESULTS: In 6 weeks, the initiative produced five conferences: antivirals, anticoagulation, pulmonology, provider resilience, and resource scarcity ethics. The average attendance was 100 (range 57-185). Among attendees providing both pre- and postconference data, group-level knowledge appeared to increase: antiviral (n = 46) pre-/postcorrect 82.6%/97.8% and incorrect 10.9%/2.2%, anticoagulation (n = 60) pre-/postcorrect 75%/93.3% and incorrect 15%/6.7%, and pulmonary (n = 21) pre-/postcorrect 66.7%/95.2% and incorrect 33.3%/4.8%. Although pulmonary management comfort appeared to increase, comfort managing of antivirals and anticoagulation was unchanged. At the conclusion of the pilot, leadership trainees reported improved self-confidence organizing multi-institutional collaborations, median (interquartile range) 58.5 (50-64) compared with baseline 34 (26-39), but did not report improved confidence in other educational or leadership skills. CONCLUSION: During crisis, trainees built a multi-institutional virtual education platform for the purposes of sharing pandemic experiences and knowledge. Accomplishment of initiative goals was mixed. Lessons learned from the process and goals may improve future disaster educational initiatives.
Authors: Nicole Yordan-Lopez; Dagmar F Hernandez-Suarez; William Marrero-Ortiz; Lorraine Marshall-Perez; Angel Lopez-Candales Journal: J Grad Med Educ Date: 2018-08
Authors: Paul V Ritschl; Nora Nevermann; Leke Wiering; Helen H Wu; Philipp Moroder; Andreas Brandl; Karl Hillebrandt; Frank Tacke; Frank Friedersdorff; Thorsten Schlomm; Wenzel Schöning; Robert Öllinger; Moritz Schmelzle; Johann Pratschke Journal: Am J Transplant Date: 2020-05-10 Impact factor: 9.369
Authors: Ana I Velazquez; Urshila Durani; Lachelle D Weeks; Ajay Major; Robby Reynolds; Ashok Kumbamu; Devika G Das; Martina C Murphy; Elizabeth Henry; Alfred I Lee; Ariela L Marshall Journal: JCO Oncol Pract Date: 2022-01-11